Page 58 - FINAL PROGRAMME 2017
P. 58

10:45 O-024
A placebo-controlled, randomized, double-blind study of pregnancy and live birth rates after single oral administration of a novel oxytocin antagonist, nolasiban, prior to embryo transfer
H. Tournaye1, A. Humberstone2, V. Lecomte2, P. Terrill3, P. Pierzynski4, E. Loumaye5 1UZ Brussel, Center for Reproductive Medicine, Brussels, Belgium
2ObsEva SA, Clinical Operations, Geneva, Switzerland
3CROS NT, Statistics, Maidenhead, United Kingdom
4Medical University of Bialystok, Reproduction Endocrinology and Gynecology, Bialystok, Poland 5ObsEva SA, Medical, Geneva, Switzerland
High-quality human preimplantation embryos actively in uence endometrial stromal cell migration
R.P. Berkhout1, C.B. Lambalk2, J. Huirne2, V. Mijatovic2, S. Repping1, G. Hamer1, S. Mastenbroek1 1Academic Medical Center, Center for Reproductive Medicine, Amsterdam, The Netherlands
2VU University Medical Center, Obstetrics and Gynecology, Amsterdam, The Netherlands
Endometrial function in women with diabetes: role of the hexosamine biosynthetic pathway (HBP)
J. Muter1, P. Ruane2, D. Brison2, J. Aplin2, M. Westwood2, J. Brosens1
1University of Warwick, Division of Biomedical Sciences, Warwick, United Kingdom
2University of Manchester, Faculty of Medical and Human Sciences, Manchester, United Kingdom
11:00 O-025
11:15 O-021

   56   57   58   59   60